China FDA Likely To Change Pricing Mechanism Of Branded Generics
This article was originally published in PharmAsia News
Executive Summary
China FDA recently announced that assessment of 75 generic drugs has been completed, and the agency sees no reason to have separate pricing policies for branded generics versus generic.